Neuritek

Next-Generation Mental Health Therapies

Min Investment: $500
Website: neuritek.com/

Company Description

Neuritek is revolutionizing mental health treatment by tackling the root cause of PTSD with next-generation therapies. Entering phase 2 clinical trials, we aim to reduce the risk, time, and cost of bringing these treatments to market. The company is pre-revenue.

Amount Raised : $10

Reveal the Score by Voting

＿

Additional ratings from other users are needed to determine a viable CrowdScore for this deal.

The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.

ⓘ

The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.

Business Idea

ⓘ

The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.

Business Traction

ⓘ

The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.

Management Team

ⓘ

The value of the company compared to similar companies raising money from investors.

Valuation

Have you done enough research to provide a rating? This is important for your fellow investors.

We only allow one revision to each rating category. Be sure about any changes.

Research Reports

No reports have been submitted

Become a Reporter

Read Our Research Disclaimer

0 Comments

To claim your deal, you must have access to @/ email

Contact support@crowdlustro.com if you need assistance.